Seminar – Ali SALAHPOUR

The seminar will be from unpublished data and focuses on testing cannabinoid compounds that can increase L-DOPA responses in a mouse model of Parkinson’s disease.

Specifically, Ali Salahpour will share results showing that increasing 2-AG levels in vivo leads to increased L-DOPA response in an acute mouse model of Parkinson’s disease.